The latest closing stock price for Blueprint Medicines as of February 20, 2025 is 94.35.
An investor who bought $1,000 worth of Blueprint Medicines stock at the IPO in 2015 would have $4,000 today, roughly 4 times their original investment - a 17.46% compound annual growth rate over 10 years.
The all-time high Blueprint Medicines stock closing price was 124.48 on December 23, 2020.
The Blueprint Medicines 52-week high stock price is 121.90, which is 29.2% above the current share price.
The Blueprint Medicines 52-week low stock price is 80.67, which is 14.5% below the current share price.
The average Blueprint Medicines stock price for the last 52 weeks is 97.30.
An investor who bought $1,000 worth of Blueprint Medicines stock at the IPO in 2015 would have $4,000 today, roughly 4 times their original investment - a 17.46% compound annual growth rate over 10 years.
The all-time high Blueprint Medicines stock closing price was 124.48 on December 23, 2020.
The Blueprint Medicines 52-week high stock price is 121.90, which is 29.2% above the current share price.
The Blueprint Medicines 52-week low stock price is 80.67, which is 14.5% below the current share price.
The average Blueprint Medicines stock price for the last 52 weeks is 97.30.